corticosteroids + immunoglobulin + romiplostim

This is a combination therapy consisting of corticosteroids, immunoglobulin (typically intravenous immunoglobulin, IVIG), and romiplostim. It is used primarily in the management of immune thrombocytopenia (ITP), especially in cases that are refractory to standard treatments. - **Corticosteroids** act as immunosuppressants, reducing platelet destruction by dampening the immune response. - **Immunoglobulins** (IVIG) provide passive immunity and modulate immune activity to decrease platelet clearance. - **Romiplostim** is a thrombopoietin receptor agonist that stimulates megakaryocytes in the bone marrow to increase platelet production by activating the thrombopoietin receptor (c-Mpl). The combination aims to both reduce destruction and enhance production of platelets, offering synergistic efficacy for patients with chronic or refractory ITP[1][3][4].